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British researchers are set to
undertake the most ambitious
project yet to exploit human
genome data to explore the links
between genes, health and
environment. If you are a Briton
aged between 45 and 69 you could
receive a rather strange phone call
early next year. It will be your
doctor, inviting you to come in for a
blood test to have your DNA stored
for posterity. Your genetic make-up
could be used to help scientists
find the cause of cancers, heart
disease and a host of other killers.
But will people leap at the chance
of donating biological material? Or
are they just too suspicious of
scientists to take part?
Up to half a million participants
will be involved in the study. They
will be asked to contribute a blood
sample, lifestyle details and their
medical histories to create a
national database of
unprecedented size. 
The UK Biobank is an ambitious
project set up with £45 million of
funding. It will collect DNA
samples from participants in
Britain and the results of analyses
will be stored on a database at the
University of Manchester, and it
will be far more than just a giant
genetic library. The volunteers will
also be asked to give details of
their lifestyle, diet and
surroundings and medical history
so that scientists can make links
between genes and the
environment.
Those who receive a call and
agree to take part will become
part of the world’s largest
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Britain is about to embark on the world’s largest genome data project
focused on middle-aged people which may shed light on the
interaction between genes, health and the environment. Nigel Williams
reports.
Doing the business: Workers analyse the DNA sequences of organisms — DNA data from more than half a million Britons will form
the basis of a new Biobank database for researchers. (Picture: Science Photo Library.)
biological database. Details of the
scheme have barely been
discussed in Britain but it has
enormous implications for society.
Its supporters say the information
would boost our scientific
understanding of the most
common diseases which cause
premature death.
The UK Biobank resource will
be managed centrally from a
coordinating centre that will have
overall responsibility for delivering
the project including data
management and quality
assurance, computing and
financial management and formal
custodianship of the data and
biological samples. It will also
coordinate several regional
centres which will be responsible
for participant recruitment and
initial data and sample collection.
The Manchester base will be set
up as a charitable company
limited by guarantee, jointly
owned by the funding partners;
the Medical Research Council, the
Wellcome Trust and the
Department of Health.
Under the scheme half a million
middle-aged people will be picked
at random and invited by their
doctor to provide general
information about their health.
They will be asked to give a blood
sample, be interviewed by a nurse
and complete a questionnaire
about their lifestyle, physical
environment, diet and health.
They will then be studied over
10, 20, 30 or maybe 50 years, to
look at how their destiny is
shaped by the twin influence of
genes and environment. In
particular, it is the biomarkers in
the blood that are present
because of the function of a gene,
which excite researchers.
There will also be a separate
oversight body to oversee the
work, independent of both the
users of the information and the
scientists involved in developing
it. The oversight body will be
responsible for ensuring that the
samples and the data collected
are used responsibly and within
the terms of the consent obtained
from the participants. But how
reassuring this will be to
participants worried about some
of the potential aspects of the
study is yet to become clear.
Scientific issues have rarely been
out of the press in recent years,
but many scientists are uneasy
about how research is reported to
the public. Despite the obvious
impact of research findings,
relatively little attention has been
paid to how and when they should
be communicated. 
A new working group, chaired
by Patrick Bateson, including
members from academic and
industrial science, scientific and
medical publishing, journalism
and consumer affairs, is beginning
with a call for evidence.
The study will examine closely
the practice of peer review. The
working group will seek views on
whether there are any other
methods of quality control or filter.
The working group will also ask
whether peer review could, or
should, be changed to provide the
public with greater confidence in
research results and whether
proposed changes in practice
might help or hinder.
For example, some journals and
archives are now experimenting
with a form of ‘open review’ in
which papers are posted on the
web and reviews are added in real
time. It has been suggested that
this ‘less secretive’ form of review
will benefit authors and referees
alike. But what are the implications
for the public? Would it mean that
more research results enter the
public domain before they have
been checked for inaccuracies?
And, of course, there are claims
that peer review is used to
suppress controversial new
findings that might be of interest to
the public, but that the scientific
and political ‘establishment’ do not
want aired. The working group
would like to receive evidence on
whether such claims are justified.
They also want to hear views on
whether there is ever a case for
researchers announcing their
results before they have been
subject to peer review.
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How results will out
Britain’s Royal Society is looking
at how research results are
communicated to the public.
Nigel Williams reports.
Throwing light: How do the results of scientific research best get presented to the
public. This is the subject of a new inquiry by Britain’s Royal Society launched last
month. (Picture: Science Photo Library.)
